col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


3 Ergebisse       Seite 1

 [1] 
Science Publications: American Journal of Pharmacology and Toxicology
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2023―Okt―20 Ribavirin Plus Therapy in Covid-19-A Single-Center Experience Budha Oinam Singh, Gaurav Chikara, Prasan Kumar Panda, Yogesh Arvind Bahurupi, Sarama Saha, Venkatesh Srinivasa Pai
2 [GO] 2022―Nov―29 Drug Repositioning in Response to COVID-19 and other Challenging Diseases Hyellavala Joseph Fomnya, Saidu Ibrahim Ngulde, Sarah Malgwi Gana, Garleya Bilbonga, Kazabu Ahmed Amshi, Chahari Alfred Midala, Kabiru Alhaji Garba
3 [GO] 2022―Aug―23 Association of Remdesivir with Poor Clinical Outcomes in COVID-19-A Single Center Experience Rajat Ranka, Prasan Kumar Panda, Yogesh Arvind Bahurupi, Disha Agarwal, Gaurav Chikara
 [1] 

3 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.150 sec